Detalhe da pesquisa
1.
CLDN18.2 BiTE Engages Effector and Regulatory T Cells for Antitumor Immune Response in Preclinical Models of Pancreatic Cancer.
Gastroenterology
; 165(5): 1219-1232, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37507075
2.
Dual Stromal Targeting Sensitizes Pancreatic Adenocarcinoma for Anti-Programmed Cell Death Protein 1 Therapy.
Gastroenterology
; 163(5): 1267-1280.e7, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35718227
3.
Tumor- and Nerve-Derived Axon Guidance Molecule Promotes Pancreatic Ductal Adenocarcinoma Progression and Metastasis through Macrophage Reprogramming.
bioRxiv
; 2023 Oct 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-37961340
4.
CCR2/CCR5 inhibitor permits the radiation-induced effector T cell infiltration in pancreatic adenocarcinoma.
J Exp Med
; 219(5)2022 05 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35404390
5.
Anti-IL-8 antibody activates myeloid cells and potentiates the anti-tumor activity of anti-PD-1 antibody in the humanized pancreatic cancer murine model.
Cancer Lett
; 539: 215722, 2022 07 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-35533951